What is MyMD Pharmaceuticals, Inc.'s current stock price?

MyMD Pharmaceuticals, Inc. (MYMD) currently trades at USD 1.81. Track real-time price changes and historical performance on AllInvestView.

What sector is MyMD Pharmaceuticals, Inc. in?

MyMD Pharmaceuticals, Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

MyMD Pharmaceuticals, Inc. MYMD · Stock Open MyMD Pharmaceuticals, Inc. in new tab

1.81 USD

Add to portfolio

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for MyMD Pharmaceuticals, Inc. (MYMD)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

MyMD Pharmaceuticals, Inc. Analysis (MYMD)

United States Health Care Official Website Stock

Is MyMD Pharmaceuticals, Inc. a good investment? MyMD Pharmaceuticals, Inc. (MYMD) is currently trading at 1.81 USD.

Investor FAQ

Does MyMD Pharmaceuticals, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is MyMD Pharmaceuticals, Inc.?

MyMD Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Exchange Ticker

NMS (United States) MYMD

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
Nov. 8, 2018	0.12
Nov. 25, 2019	1:25
April 19, 2021	1:2
Feb. 15, 2024	0.03

MyMD Pharmaceuticals, Inc. MYMD · Stock Open MyMD Pharmaceuticals, Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

MyMD Pharmaceuticals, Inc. Analysis (MYMD)

Investor FAQ

Company Profile

Fundamentals

Under Construction

MyMD Pharmaceuticals, Inc. MYMD · Stock Open MyMD Pharmaceuticals, Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

MyMD Pharmaceuticals, Inc. Analysis (MYMD)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications